The diagnostic performance of AFP combined with ALT, AST, and NLR for HBV‐HCC is significantly superior to single biomarkers or any other combinations among all patients and most subgroups, especially in normal serum AFP concentration group and 40‐60 years group, which will be performed in further clinical practice. The gene discussed is AFP; the disease is hepatocellular carcinoma.